Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Depress Anxiety. 2012 May 4;29(6):531–540. doi: 10.1002/da.21959

Figure 1.

Figure 1

Scores on the rating scale for PMTS (mean + SEM) were significantly improved compared with baseline on the second day after the start of SRI treatment (Day 1). Improvement was maintained until menses (ANOVA-R: F4,40 = 9.1, P = .001; Bonferroni t ≤ 3.8, df = 40, P ≤ .01). Seven of 12 women experienced a 50% reduction relative to baseline within 2 days of treatment.